Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials-Reference-Cited by-同舟云学术

Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials

Published:2017-02-17 Issue:7 Volume:106 Page:501-513
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Wolff Georg,Lin Yingfeng,Karathanos Athanasios,Brockmeyer Maximilian,Wolters Susanne,Nowak Bernd,Fürnkranz Alexander,Makimoto Hisaki,Kelm Malte,Schulze Volker

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s00392-017-1079-0/fulltext.html

Reference48 articles.

1. Franciosa JA, Wilen M, Ziesche S, Cohn JN (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831–836

2. Zipes DP, Wellens HJJ (1998) Sudden cardiac death. Circulation 98:2334–2351

3. Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124:1035–1045

4. Sweeney MO, Ruskin JN (1994) Mortality benefits and the implantable cardioverter-defibrillator. Circulation 89:1851–1858

5. Uretsky BF, Sheahan RG (1997) Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol 30:1589–1597

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical rehabilitation in heart failure with reduced ejection fraction: are the cardiac implantable devices a barrier?;Balneo and PRM Research Journal;2023-12-20

2. Two-Year Outcomes of Primary Prophylactic Use of Defibrillators for Ischemic and Non-Ischemic Cardiomyopathy　― Propensity Score-Matched Analysis From the Nippon Storm Study ―;Circulation Journal;2023-12-07

3. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure);American Heart Journal;2023-12

4. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches;The Lancet;2023-09

5. The pivotal role of ECG in cardiomyopathies;Frontiers in Cardiovascular Medicine;2023-06-19